Interoperability of time series cytometric data: A cross platform approach for modeling tumor heterogeneity

Imtiaz A. Khan, Monica Lupi, Lee Campbell, Sally C. Chappell, M. Rowan Brown, Marie Wiltshire, Paul J. Smith, Paolo Ubezio, Rachel J. Errington

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The cell cycle, with its highly conserved features, is a fundamental driver for the temporal control of cell proliferation-while abnormal control and modulation of the cell cycle are characteristic of tumor cells. The principle aim in cancer biology is to seek anunderstanding of the origin and nature of innate and acquired heterogeneity at the cellular level, driven principally by temporal and functional asynchrony. A major bottleneck when mathematically modeling these biological systems is the lack of interlinked structured experimental data. This often results in the in silico models failing to translate the specific hypothesis into parameterized terms that enable robust validation and hence would produce suitable prediction tools rather than just simulation tools. The focus has been on linking data originating from different cytometric platforms and cell-based event analysis to inform and constrain the input parameters of a compartmental cell cycle model, hence partly measuring and deconvolving cell cycle heterogeneity within a tumor population. Our work has addressed the concept that the interoperability of cytometric data, derived from different cytometry platforms, can complement as well as enhance cellular parameters space, thus providing a more broader and in-depth view of the cellular systems. The initial aim was to enable the cell cycle model to deliver an improved integrated simulation of the well-defined and constrained biological system. From a modeling perspective, such a cross platform approach has provided a paradigm shift from conventional cross-validation approaches, and from a bioinformatics perspective, novel computational methodology has been introduced for integrating and mapping continuous data with cross-sectional data. This establishes the foundation for developing predictive models and in silico tracking and prediction of tumor progression.

Original languageEnglish
Pages (from-to)214-226
Number of pages13
JournalCytometry Part A
Volume79 A
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Cell Cycle
Computer Simulation
Neoplasms
Cell Cycle Checkpoints
Computational Biology
Cell Proliferation
Population

Keywords

  • Bioinformatics
  • Cell cycle
  • Data interoperability
  • Flow cytometry
  • Lineage
  • Mathematical modeling
  • Timelapse microscopy

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Pathology and Forensic Medicine

Cite this

Khan, I. A., Lupi, M., Campbell, L., Chappell, S. C., Brown, M. R., Wiltshire, M., ... Errington, R. J. (2011). Interoperability of time series cytometric data: A cross platform approach for modeling tumor heterogeneity. Cytometry Part A, 79 A(3), 214-226. https://doi.org/10.1002/cyto.a.21023

Interoperability of time series cytometric data : A cross platform approach for modeling tumor heterogeneity. / Khan, Imtiaz A.; Lupi, Monica; Campbell, Lee; Chappell, Sally C.; Brown, M. Rowan; Wiltshire, Marie; Smith, Paul J.; Ubezio, Paolo; Errington, Rachel J.

In: Cytometry Part A, Vol. 79 A, No. 3, 03.2011, p. 214-226.

Research output: Contribution to journalArticle

Khan, IA, Lupi, M, Campbell, L, Chappell, SC, Brown, MR, Wiltshire, M, Smith, PJ, Ubezio, P & Errington, RJ 2011, 'Interoperability of time series cytometric data: A cross platform approach for modeling tumor heterogeneity', Cytometry Part A, vol. 79 A, no. 3, pp. 214-226. https://doi.org/10.1002/cyto.a.21023
Khan, Imtiaz A. ; Lupi, Monica ; Campbell, Lee ; Chappell, Sally C. ; Brown, M. Rowan ; Wiltshire, Marie ; Smith, Paul J. ; Ubezio, Paolo ; Errington, Rachel J. / Interoperability of time series cytometric data : A cross platform approach for modeling tumor heterogeneity. In: Cytometry Part A. 2011 ; Vol. 79 A, No. 3. pp. 214-226.
@article{c99ea484a5d945b3b4d32a9a0de7a7ed,
title = "Interoperability of time series cytometric data: A cross platform approach for modeling tumor heterogeneity",
abstract = "The cell cycle, with its highly conserved features, is a fundamental driver for the temporal control of cell proliferation-while abnormal control and modulation of the cell cycle are characteristic of tumor cells. The principle aim in cancer biology is to seek anunderstanding of the origin and nature of innate and acquired heterogeneity at the cellular level, driven principally by temporal and functional asynchrony. A major bottleneck when mathematically modeling these biological systems is the lack of interlinked structured experimental data. This often results in the in silico models failing to translate the specific hypothesis into parameterized terms that enable robust validation and hence would produce suitable prediction tools rather than just simulation tools. The focus has been on linking data originating from different cytometric platforms and cell-based event analysis to inform and constrain the input parameters of a compartmental cell cycle model, hence partly measuring and deconvolving cell cycle heterogeneity within a tumor population. Our work has addressed the concept that the interoperability of cytometric data, derived from different cytometry platforms, can complement as well as enhance cellular parameters space, thus providing a more broader and in-depth view of the cellular systems. The initial aim was to enable the cell cycle model to deliver an improved integrated simulation of the well-defined and constrained biological system. From a modeling perspective, such a cross platform approach has provided a paradigm shift from conventional cross-validation approaches, and from a bioinformatics perspective, novel computational methodology has been introduced for integrating and mapping continuous data with cross-sectional data. This establishes the foundation for developing predictive models and in silico tracking and prediction of tumor progression.",
keywords = "Bioinformatics, Cell cycle, Data interoperability, Flow cytometry, Lineage, Mathematical modeling, Timelapse microscopy",
author = "Khan, {Imtiaz A.} and Monica Lupi and Lee Campbell and Chappell, {Sally C.} and Brown, {M. Rowan} and Marie Wiltshire and Smith, {Paul J.} and Paolo Ubezio and Errington, {Rachel J.}",
year = "2011",
month = "3",
doi = "10.1002/cyto.a.21023",
language = "English",
volume = "79 A",
pages = "214--226",
journal = "Cytometry. Part A : the journal of the International Society for Analytical Cytology",
issn = "1552-4922",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Interoperability of time series cytometric data

T2 - A cross platform approach for modeling tumor heterogeneity

AU - Khan, Imtiaz A.

AU - Lupi, Monica

AU - Campbell, Lee

AU - Chappell, Sally C.

AU - Brown, M. Rowan

AU - Wiltshire, Marie

AU - Smith, Paul J.

AU - Ubezio, Paolo

AU - Errington, Rachel J.

PY - 2011/3

Y1 - 2011/3

N2 - The cell cycle, with its highly conserved features, is a fundamental driver for the temporal control of cell proliferation-while abnormal control and modulation of the cell cycle are characteristic of tumor cells. The principle aim in cancer biology is to seek anunderstanding of the origin and nature of innate and acquired heterogeneity at the cellular level, driven principally by temporal and functional asynchrony. A major bottleneck when mathematically modeling these biological systems is the lack of interlinked structured experimental data. This often results in the in silico models failing to translate the specific hypothesis into parameterized terms that enable robust validation and hence would produce suitable prediction tools rather than just simulation tools. The focus has been on linking data originating from different cytometric platforms and cell-based event analysis to inform and constrain the input parameters of a compartmental cell cycle model, hence partly measuring and deconvolving cell cycle heterogeneity within a tumor population. Our work has addressed the concept that the interoperability of cytometric data, derived from different cytometry platforms, can complement as well as enhance cellular parameters space, thus providing a more broader and in-depth view of the cellular systems. The initial aim was to enable the cell cycle model to deliver an improved integrated simulation of the well-defined and constrained biological system. From a modeling perspective, such a cross platform approach has provided a paradigm shift from conventional cross-validation approaches, and from a bioinformatics perspective, novel computational methodology has been introduced for integrating and mapping continuous data with cross-sectional data. This establishes the foundation for developing predictive models and in silico tracking and prediction of tumor progression.

AB - The cell cycle, with its highly conserved features, is a fundamental driver for the temporal control of cell proliferation-while abnormal control and modulation of the cell cycle are characteristic of tumor cells. The principle aim in cancer biology is to seek anunderstanding of the origin and nature of innate and acquired heterogeneity at the cellular level, driven principally by temporal and functional asynchrony. A major bottleneck when mathematically modeling these biological systems is the lack of interlinked structured experimental data. This often results in the in silico models failing to translate the specific hypothesis into parameterized terms that enable robust validation and hence would produce suitable prediction tools rather than just simulation tools. The focus has been on linking data originating from different cytometric platforms and cell-based event analysis to inform and constrain the input parameters of a compartmental cell cycle model, hence partly measuring and deconvolving cell cycle heterogeneity within a tumor population. Our work has addressed the concept that the interoperability of cytometric data, derived from different cytometry platforms, can complement as well as enhance cellular parameters space, thus providing a more broader and in-depth view of the cellular systems. The initial aim was to enable the cell cycle model to deliver an improved integrated simulation of the well-defined and constrained biological system. From a modeling perspective, such a cross platform approach has provided a paradigm shift from conventional cross-validation approaches, and from a bioinformatics perspective, novel computational methodology has been introduced for integrating and mapping continuous data with cross-sectional data. This establishes the foundation for developing predictive models and in silico tracking and prediction of tumor progression.

KW - Bioinformatics

KW - Cell cycle

KW - Data interoperability

KW - Flow cytometry

KW - Lineage

KW - Mathematical modeling

KW - Timelapse microscopy

UR - http://www.scopus.com/inward/record.url?scp=79951962588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951962588&partnerID=8YFLogxK

U2 - 10.1002/cyto.a.21023

DO - 10.1002/cyto.a.21023

M3 - Article

C2 - 21337698

AN - SCOPUS:79951962588

VL - 79 A

SP - 214

EP - 226

JO - Cytometry. Part A : the journal of the International Society for Analytical Cytology

JF - Cytometry. Part A : the journal of the International Society for Analytical Cytology

SN - 1552-4922

IS - 3

ER -